|
|
|
Insider
Information: |
Emster Kurt Von |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
302,614 |
|
Indirect Shares
|
18,297,697 |
|
|
Direct
Value |
$6,276,934 |
|
|
Indirect Value
|
$171,984,175 |
|
|
Total
Shares |
18,600,311 |
|
|
Total
Value |
$178,261,109 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
173,611 |
2004-02-19 |
4,350,516 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Crispr Therapeutics Ag |
CRSP |
Director |
2018-06-05 |
90,000 |
2018-12-18 |
1,171,268 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-09-29 |
18,406 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Vaxcyte, Inc. |
PCVX |
Director |
2020-06-16 |
0 |
2020-06-16 |
4,168,718 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-17 |
17,828 |
2021-05-18 |
2,960,231 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-04-13 |
21,175 |
2021-09-24 |
5,628,558 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-02-19 |
4 |
S |
$20.00 |
$3,447,460 |
I/I |
(172,373) |
4,350,516 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2006-09-11 |
4 |
S |
$14.00 |
$43,290 |
I/I |
(3,089) |
470,718 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-10 |
4 |
S |
$15.65 |
$391,325 |
I/I |
(25,000) |
445,718 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-11 |
4 |
S |
$14.62 |
$468,865 |
I/I |
(32,060) |
413,658 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-14 |
4 |
S |
$14.80 |
$537,403 |
I/I |
(36,300) |
377,358 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-09-05 |
4 |
S |
$0.29 |
$396 |
I/I |
(1,367) |
25,712 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2017-09-28 |
4 |
S |
$8.15 |
$736,670 |
I/I |
(90,389) |
1,509,611 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2017-09-29 |
4 |
S |
$8.04 |
$970,709 |
I/I |
(120,735) |
1,388,876 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2017-10-02 |
4 |
S |
$7.93 |
$300,832 |
I/I |
(37,936) |
1,350,940 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2017-10-03 |
4 |
S |
$7.81 |
$554,041 |
I/I |
(70,940) |
1,280,000 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-05-11 |
4 |
S |
$51.73 |
$13,209,900 |
I/I |
(250,000) |
1,637,202 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-05-14 |
4 |
S |
$52.20 |
$22,142,556 |
I/I |
(400,000) |
1,237,202 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-06-05 |
4 |
S |
$12.51 |
$11,509 |
I/I |
(920) |
18,316 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-12-17 |
4 |
S |
$33.17 |
$99,797 |
I/I |
(3,009) |
1,234,193 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-12-17 |
4 |
S |
$8.17 |
$726,223 |
I/I |
(88,889) |
184,528 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-12-18 |
4 |
S |
$7.43 |
$397,365 |
I/I |
(53,492) |
131,036 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-12-18 |
4/A |
S |
$29.70 |
$1,869,168 |
I/I |
(62,925) |
1,171,268 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-12-18 |
4 |
S |
$29.70 |
$2,077,101 |
I/I |
(69,925) |
1,164,268 |
0 |
- |
|
AMHCU |
Amplitude Healthcare Acqu... |
Director |
|
2023-04-13 |
4 |
S |
$1.49 |
$13,524 |
D/D |
(9,075) |
21,175 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2018-06-05 |
4 |
OE |
$5.75 |
$11,500 |
I/I |
2,000 |
19,236 |
0 |
- |
|
CBAY |
Cymabay Therapeutics, Inc... |
Director |
|
2023-09-29 |
4 |
OE |
$5.00 |
$79,605 |
D/D |
15,921 |
105,921 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
173,611 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2003-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,340,278 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|